SCHEMBL3922973

SCHEMBL3922973

N#CCN1CCCCC1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.58
CHRM5 P08912 4/20 0.58
CHRM1 P11229 4/20 0.58
CHRM3 P20309 4/20 0.58
CHRM4 P08173 2/20 0.58
CYP2D6 P10635 2/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
ALDH1A1 P00352 3/20 0.49
LMNA P02545 2/20 0.49
APEX1 P27695 2/20 0.49
PMP22 Q01453 2/20 0.49
TSHR P16473 1/20 0.49
ALOX12 P18054 1/20 0.49
NFKB1 P19838 1/20 0.49
MAPK1 P28482 1/20 0.49
BLM P54132 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PIK3CD O00329 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28729222 0.98 CHRM2 (0.56) CHRM2CHRM5CHRM1CHRM3CHRM4
SCHEMBL163174 0.93
SCHEMBL9057404 0.83 CHRM2 (0.58) CHRM2CHRM5CHRM1CHRM3CHRM4
SCHEMBL2705010 0.81 CHRM2 (0.56) CHRM2CHRM5CHRM1CHRM3CHRM4
SCHEMBL14408262 0.79 CHRM2 (0.46) CHRM2CHRM5CHRM1CHRM3CHRM4
SCHEMBL6502219 0.79 CHRM2 (0.55) CHRM2CHRM5CHRM1CHRM3CHRM4
SCHEMBL5081884 0.78 L3MBTL1 (0.46) CHRM2CHRM5CHRM1CHRM3CHRM4
SCHEMBL11726121 0.78 CHRM2 (0.93) CHRM2CHRM5CHRM1CHRM3CHRM4
SCHEMBL11721410 0.76 CHRM2 (0.89) CHRM2CHRM5CHRM1CHRM3CHRM4
SCHEMBL10975898 0.76 CHRM2 (0.66) CHRM2CHRM5CHRM1CHRM3CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009009117-A2 CHEMOENZYMATIC PROCESSES FOR PREPARATION OF LEVETIRACETAM BIOVERDANT, INC. (US) 2009-01-15 WO claimed
WO-2022037694-A1 A CLASS OF FIVE- AND SIX-MEMBERED HETEROCYCLIC COMPOUNDS AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITORS 轶诺(浙江)药业有限公司 2022-02-24 WO disclosed
WO-2009009117-A2 CHEMOENZYMATIC PROCESSES FOR PREPARATION OF LEVETIRACETAM BIOVERDANT, INC. (US) 2009-01-15 WO disclosed